Synthetic cannabinoids: Analysis and metabolites

被引:106
|
作者
ElSohly, Mahmoud A. [1 ,2 ,3 ]
Gul, Waseem [1 ,2 ]
Wanas, Amira S. [2 ,4 ]
Radwan, Mohamed M. [2 ,5 ]
机构
[1] ElSohly Labs Inc, Oxford, MS 38655 USA
[2] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA
[3] Univ Mississippi, Sch Pharm, Dept Pharmaceut, University, MS 38677 USA
[4] Menia Univ, Fac Pharm, Dept Pharmacognosy, Al Minya, Egypt
[5] Univ Alexandria, Fac Pharm, Dept Pharmacognosy, Alexandria, Egypt
关键词
Synthetic cannabinoids; Analysis; Herbal products; Metabolites; CHROMATOGRAPHY-MASS SPECTROMETRY; DESIGNER DRUGS; HERBAL BLENDS; IN-VITRO; LC-MS/MS; IDENTIFICATION; JWH-018; QUANTIFICATION; VALIDATION; TOF;
D O I
10.1016/j.lfs.2013.12.212
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cannabimimetics (commonly referred to as synthetic cannabinoids), a group of compounds encompassing a wide range of chemical structures, have been developed by scientists with the hope of achieving selectivity toward one or the other of the cannabinoid receptors CB1 and CB2. The goal was to have compounds that could possess high therapeutic activity without many side effects. However, underground laboratories have used the information generated by the scientific community to develop these compounds for illicit use as marijuana substitutes. This chapter reviews the different classes of these "synthetic cannabinoids" with particular emphasis on the methods used for their identification in the herbal products with which they are mixed and identification of their metabolites in biological specimens. (C) 2014 Published by Elsevier Inc.
引用
收藏
页码:78 / 90
页数:13
相关论文
共 50 条
  • [31] Synthetic cannabinoids and driving
    Mura, Patrick
    Brunet, Bertrand
    TOXICOLOGIE ANALYTIQUE ET CLINIQUE, 2015, 27 (01) : 41 - 44
  • [32] Nonpsychotropic synthetic cannabinoids
    Pop, E
    CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (13) : 1347 - 1359
  • [33] Cathinones and synthetic cannabinoids
    Preuss, Ulrich W.
    Schoett, Katharina
    SUCHTTHERAPIE, 2022, 23 (02) : 94 - 104
  • [34] Toxicology of synthetic cannabinoids
    Moutaouakkil, Youssef
    Mounir, Radia
    El Cadi, Mina Ait
    Lamsaouri, Jamal
    Bousliman, Yassir
    Eljaoudi, Rachid
    ANNALES DE BIOLOGIE CLINIQUE, 2024, 82 (02) : 151 - 173
  • [35] Psychosis and synthetic cannabinoids
    Deng, Huiqiong
    Verrico, Christopher D.
    Kosten, Thomas R.
    Nielsen, David A.
    PSYCHIATRY RESEARCH, 2018, 268 : 400 - 412
  • [36] Synthetic cannabinoids in the kidneys
    Alp, Alper
    Akdam, Hakan
    Avcioglu, Banu Yilmaz
    Ersan, Sibel
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (01): : 10 - 12
  • [37] Synthetic cannabinoids - Preface
    Pop, E
    CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (13) : U2 - U2
  • [38] Regulation of synthetic cannabinoids
    Sumnall, Harry
    LANCET, 2009, 374 (9701): : 1595 - 1595
  • [39] The Synthetic Cannabinoids Phenomenon
    Karila, Laurent
    Benyamina, Amine
    Blecha, Lisa
    Cottencin, Olivier
    Billieux, Joel
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (42) : 6420 - 6425